Yüklüyor......
The (Ir)relevance of Group Size in Health Care Priority Setting: A Reply to Juth
How to handle orphan drugs for rare diseases is a pressing problem in current health-care. Due to the group size of patients affecting the cost of treatment, they risk being disadvantaged in relation to existing cost-effectiveness thresholds. In an article by Niklas Juth it has been argued that it i...
Kaydedildi:
| Yayımlandı: | Health Care Anal |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5313590/ https://ncbi.nlm.nih.gov/pubmed/27734213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10728-016-0333-3 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|